JP2008545801A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008545801A5 JP2008545801A5 JP2008516020A JP2008516020A JP2008545801A5 JP 2008545801 A5 JP2008545801 A5 JP 2008545801A5 JP 2008516020 A JP2008516020 A JP 2008516020A JP 2008516020 A JP2008516020 A JP 2008516020A JP 2008545801 A5 JP2008545801 A5 JP 2008545801A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- independently
- compound
- alkyl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 31
- 125000000217 alkyl group Chemical group 0.000 claims 16
- 125000000623 heterocyclic group Chemical group 0.000 claims 13
- 125000001072 heteroaryl group Chemical group 0.000 claims 12
- 125000003118 aryl group Chemical group 0.000 claims 11
- 125000003545 alkoxy group Chemical group 0.000 claims 9
- 125000004122 cyclic group Chemical group 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 9
- 239000001257 hydrogen Substances 0.000 claims 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 8
- 125000003342 alkenyl group Chemical group 0.000 claims 8
- 125000001475 halogen functional group Chemical group 0.000 claims 7
- 150000002431 hydrogen Chemical class 0.000 claims 7
- 125000000304 alkynyl group Chemical group 0.000 claims 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims 6
- 125000001188 haloalkyl group Chemical group 0.000 claims 6
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- -1 nitro, hydroxy Chemical group 0.000 claims 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims 2
- 125000004438 haloalkoxy group Chemical group 0.000 claims 2
- 125000004995 haloalkylthio group Chemical group 0.000 claims 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 2
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 150000002825 nitriles Chemical class 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims 1
- 125000005018 aryl alkenyl group Chemical group 0.000 claims 1
- 125000005015 aryl alkynyl group Chemical group 0.000 claims 1
- 125000005160 aryl oxy alkyl group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical group C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 150000003852 triazoles Chemical group 0.000 claims 1
- 0 C*(C)C(*)(*(C)N(C)*)*=C Chemical compound C*(C)C(*)(*(C)N(C)*)*=C 0.000 description 3
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68970905P | 2005-06-10 | 2005-06-10 | |
| PCT/US2006/022789 WO2006135860A1 (en) | 2005-06-10 | 2006-06-12 | Sulfonamide compounds and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008545801A JP2008545801A (ja) | 2008-12-18 |
| JP2008545801A5 true JP2008545801A5 (https=) | 2009-07-16 |
Family
ID=37532637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008516020A Pending JP2008545801A (ja) | 2005-06-10 | 2006-06-12 | スルホンアミド化合物およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060293370A1 (https=) |
| EP (1) | EP1893569A4 (https=) |
| JP (1) | JP2008545801A (https=) |
| CN (1) | CN101248042A (https=) |
| CA (1) | CA2611493A1 (https=) |
| EA (1) | EA200800013A1 (https=) |
| MX (1) | MX2007015617A (https=) |
| NO (1) | NO20076694L (https=) |
| WO (1) | WO2006135860A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7829589B2 (en) | 2005-06-10 | 2010-11-09 | Elixir Pharmaceuticals, Inc. | Sulfonamide compounds and uses thereof |
| EP1757290A1 (en) * | 2005-08-16 | 2007-02-28 | Zentaris GmbH | Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| WO2008141189A1 (en) * | 2007-05-09 | 2008-11-20 | Elixir Pharmaceuticals, Inc. | Ghrelin modulating compounds and combinations thereof |
| EP2349266A4 (en) * | 2008-10-30 | 2012-06-06 | Elixir Pharmaceuticals Inc | Sulphonamide-containing compounds and their uses |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| WO2011092290A1 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
| AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
| EP2531490B1 (en) | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexyl amide derivatives as crf receptor antagonists |
| US10039813B2 (en) | 2012-02-07 | 2018-08-07 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| WO2014144231A1 (en) | 2013-03-15 | 2014-09-18 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
| WO2015015519A1 (en) * | 2013-07-31 | 2015-02-05 | Council Of Scientific & Industrial Research | Novel indazole compounds and a process for the preparation thereof |
| WO2016138099A1 (en) | 2015-02-24 | 2016-09-01 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3647790A (en) * | 1969-04-08 | 1972-03-07 | American Home Prod | Ouinoxalinyl-oxazolidines and -oxazines |
| IE70217B1 (en) * | 1990-08-15 | 1996-10-30 | British Bio Technology | Benzimidazole derivatives process for their preparation and application |
| US5254715A (en) * | 1990-11-07 | 1993-10-19 | Warner-Lambert Company | Aminosulfonyl carbamates |
| GB9200245D0 (en) * | 1992-01-07 | 1992-02-26 | British Bio Technology | Compounds |
| GB9202791D0 (en) * | 1992-02-11 | 1992-03-25 | British Bio Technology | Compounds |
| GB9804426D0 (en) * | 1998-03-02 | 1998-04-29 | Pfizer Ltd | Heterocycles |
| SK13652002A3 (sk) * | 2000-03-31 | 2004-01-08 | Pfizer Products Inc. | Deriváty piperazínu |
| GB0031321D0 (en) * | 2000-12-21 | 2001-02-07 | Pfizer Ltd | Treatment |
| MXPA04012642A (es) * | 2002-06-14 | 2005-03-23 | Merck & Co Inc | Inhibidores de la cinesina mitotica. |
| MY139563A (en) * | 2002-09-04 | 2009-10-30 | Bristol Myers Squibb Co | Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| WO2004071448A2 (en) * | 2003-02-12 | 2004-08-26 | Transtech Pharma Inc. | Substituted azole derivatives as inhibitors of protein tyrosine phosphatases |
| WO2004103993A1 (en) * | 2003-05-14 | 2004-12-02 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
| CA2561801A1 (en) * | 2004-04-02 | 2005-10-20 | Elixir Pharmaceuticals, Inc. | Sulfonamides and uses thereof |
-
2006
- 2006-06-12 EA EA200800013A patent/EA200800013A1/ru unknown
- 2006-06-12 US US11/451,086 patent/US20060293370A1/en not_active Abandoned
- 2006-06-12 EP EP06784776A patent/EP1893569A4/en not_active Withdrawn
- 2006-06-12 CN CNA2006800271149A patent/CN101248042A/zh active Pending
- 2006-06-12 CA CA002611493A patent/CA2611493A1/en not_active Abandoned
- 2006-06-12 WO PCT/US2006/022789 patent/WO2006135860A1/en not_active Ceased
- 2006-06-12 MX MX2007015617A patent/MX2007015617A/es unknown
- 2006-06-12 JP JP2008516020A patent/JP2008545801A/ja active Pending
-
2007
- 2007-12-28 NO NO20076694A patent/NO20076694L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008545801A5 (https=) | ||
| JP2009533410A5 (https=) | ||
| JP2011522789A5 (https=) | ||
| JP2013504593A5 (https=) | ||
| JP2005510476A5 (https=) | ||
| JP2009511490A5 (https=) | ||
| JP2005526076A5 (https=) | ||
| CA2494047A1 (en) | Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles | |
| JP2007531739A5 (https=) | ||
| JP2012504608A5 (https=) | ||
| JP2010504286A5 (https=) | ||
| WO2007075629A3 (en) | Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists | |
| JP2006508979A5 (https=) | ||
| EP1325921A3 (en) | Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators | |
| JP2009515872A5 (https=) | ||
| JP2005534685A5 (https=) | ||
| JP2006528646A5 (https=) | ||
| WO2010053583A3 (en) | Small molecule cd4 mimetics and uses thereof | |
| JP2007529534A5 (https=) | ||
| JP2010077137A5 (https=) | ||
| JP2008504304A5 (https=) | ||
| JP2011509261A5 (https=) | ||
| JP2009534853A5 (https=) | ||
| JP2008530102A5 (https=) | ||
| JP2009526868A5 (https=) |